To summarize the impact of contemporary hematologic treatments on female reproductive function and evaluate current fertility preservation strategies, emphasizing long-term quality-of-life outcomes.
Key Findings:
Female survivors of leukemia and lymphoma face high risks of premature ovarian insufficiency and diminished ovarian reserve due to treatment.
Fertility preservation strategies have evolved, with options like oocyte cryopreservation and ovarian tissue cryopreservation becoming more accessible.
Young female patients with hematologic malignancies are often less informed about fertility preservation compared to other cancer populations, and there is a risk of malignant cell reintroduction.
Interpretation:
Integrating early, multidisciplinary oncofertility counseling into standard care is essential to optimize reproductive outcomes and ensure equitable access to fertility preservation for young cancer survivors.
Limitations:
Time constraints due to the urgency of treatment can limit the feasibility of fertility preservation interventions.
Psychosocial complexities and ethical considerations complicate decision-making for adolescents and their families.
Variability in the availability of fertility preservation procedures across regions and the high costs associated with them pose significant barriers, alongside prognostic uncertainty.
Conclusion:
Early and comprehensive fertility preservation planning, integrated with oncofertility counseling, is crucial for optimizing reproductive outcomes in young female patients with blood cancers.
